GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shelter Pharma Ltd (BOM:543963) » Definitions » Beneish M-Score

Shelter Pharma (BOM:543963) Beneish M-Score : -0.30 (As of Apr. 16, 2025)


View and export this data going back to 2023. Start your Free Trial

What is Shelter Pharma Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -0.3 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Shelter Pharma's Beneish M-Score or its related term are showing as below:

BOM:543963' s Beneish M-Score Range Over the Past 10 Years
Min: -1.42   Med: -0.3   Max: 1.61
Current: -0.3

During the past 5 years, the highest Beneish M-Score of Shelter Pharma was 1.61. The lowest was -1.42. And the median was -0.30.


Shelter Pharma Beneish M-Score Historical Data

The historical data trend for Shelter Pharma's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shelter Pharma Beneish M-Score Chart

Shelter Pharma Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Beneish M-Score
- - -1.42 1.61 -0.30

Shelter Pharma Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Beneish M-Score Get a 7-Day Free Trial - 1.61 - -0.30 -

Competitive Comparison of Shelter Pharma's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Shelter Pharma's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shelter Pharma's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shelter Pharma's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Shelter Pharma's Beneish M-Score falls into.


;
;

Shelter Pharma Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Shelter Pharma for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9755+0.528 * 0.9847+0.404 * 2.9482+0.892 * 1.1071+0.115 * 1.2673
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.8249+4.679 * 0.212329-0.327 * 0.1722
=-0.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Total Receivables was ₹88.5 Mil.
Revenue was ₹400.2 Mil.
Gross Profit was ₹106.8 Mil.
Total Current Assets was ₹297.2 Mil.
Total Assets was ₹379.1 Mil.
Property, Plant and Equipment(Net PPE) was ₹35.7 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹2.5 Mil.
Selling, General, & Admin. Expense(SGA) was ₹0.9 Mil.
Total Current Liabilities was ₹14.7 Mil.
Long-Term Debt & Capital Lease Obligation was ₹5.7 Mil.
Net Income was ₹62.0 Mil.
Gross Profit was ₹0.0 Mil.
Cash Flow from Operations was ₹-18.5 Mil.
Total Receivables was ₹81.9 Mil.
Revenue was ₹361.5 Mil.
Gross Profit was ₹95.0 Mil.
Total Current Assets was ₹187.2 Mil.
Total Assets was ₹214.5 Mil.
Property, Plant and Equipment(Net PPE) was ₹18.5 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹1.6 Mil.
Selling, General, & Admin. Expense(SGA) was ₹1.0 Mil.
Total Current Liabilities was ₹62.5 Mil.
Long-Term Debt & Capital Lease Obligation was ₹4.8 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(88.501 / 400.229) / (81.947 / 361.527)
=0.221126 / 0.226669
=0.9755

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(94.961 / 361.527) / (106.763 / 400.229)
=0.262666 / 0.266755
=0.9847

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (297.188 + 35.708) / 379.148) / (1 - (187.159 + 18.45) / 214.484)
=0.121989 / 0.041378
=2.9482

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=400.229 / 361.527
=1.1071

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1.641 / (1.641 + 18.45)) / (2.46 / (2.46 + 35.708))
=0.081678 / 0.064452
=1.2673

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0.905 / 400.229) / (0.991 / 361.527)
=0.002261 / 0.002741
=0.8249

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((5.732 + 14.749) / 379.148) / ((4.8 + 62.478) / 214.484)
=0.054018 / 0.313674
=0.1722

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(62.002 - 0 - -18.502) / 379.148
=0.212329

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Shelter Pharma has a M-score of -0.30 signals that the company is likely to be a manipulator.


Shelter Pharma Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Shelter Pharma's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Shelter Pharma Business Description

Traded in Other Exchanges
N/A
Address
Opp. MJ Library Ashram Road, 5th Floor, 501 Sakar 4, Paldi, Ellisbridge, Ahmedabad, GJ, IND, 380006
Shelter Pharma Ltd focuses in manufacturing herbal products with a well-built presence in Human Pharma as well as the Veterinary space. It is present in most of the non-critical segments of human and veterinary pharma through its well-spread portfolio. Its products include tablets, syrups, baby drops, barley water, oils, powders, ointments, etc.

Shelter Pharma Headlines

No Headlines